but without the protein. clinical trials

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart in Participants with Sjögren’s Disease

This study is looking at a new medicine called Abiprubart for Sjögren’s disease. It's a key step to see how well it works and if it's safe. The trial involves different doses and uses a dummy medicine for comparison.